Free Trial
→ This Signal Only Flashes Once Every 4 Years – And It Just Triggered (From Crypto Swap Profits) (Ad) Free TEVA Stock Alerts

Teva Pharmaceutical Industries (TEVA) SEC Filings & 10K Form

Teva Pharmaceutical Industries logo
$16.22 +0.21 (+1.28%)
As of 12:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Teva Pharmaceutical Industries SEC Filings

Export to Excel
DateFilerForm TypeView
06/09/2025
3:15 PM		Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:18 PM		Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:20 PM		Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:22 PM		Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:25 PM		Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:52 PM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
3:16 PM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
4:13 PM		Teva Pharmaceutical Industries (Subject)
Form FWP
05/19/2025
5:50 AM		Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Finance Netherlands IV B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
Form 424B5
05/08/2025
1:34 PM		Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:00 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
3:06 PM		Teva Pharmaceutical Industries (Filer)
Form DEF 14A
04/07/2025
3:01 PM		Lippman Evan (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2025
3:22 PM		McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:25 PM		Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:29 PM		Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:13 PM		Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:16 PM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM		Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:06 PM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:08 PM		Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:11 PM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:13 PM		Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:29 PM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:08 PM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:14 PM		McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
03/04/2025
5:57 PM		McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:02 PM		Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:30 PM		Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:37 PM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:44 PM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:07 PM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:59 AM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:14 PM		Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
10:52 AM		Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
11:38 AM		Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
7:06 AM		Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
3:06 PM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:03 PM		BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:04 PM		Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
11/20/2024
10:39 AM		Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
9:34 AM		FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G
11/06/2024
3:06 PM		Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:00 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
6:40 AM		Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:06 AM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/14/2024
5:24 AM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/12/2024
3:09 PM		Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
6:32 AM		Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:35 AM		Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:30 AM		Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
3:06 PM		Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
6:00 AM		Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:TEVA) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
The DOJ Just Paved the Way for Account Seizures
Washington is running out of money…And guess where they'll look next? When governments go broke, they take ...
Priority Gold | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...
Brownstone Research | Sponsored